EQUIP is a company.
EQUIP has raised $400K across 1 funding round.
Key people at EQUIP.
EQUIP has raised $400K in total across 1 funding round.
EQUIP has raised $400K in total across 1 funding round.
EQUIP's investors include GateCap Ventures, MaC Venture Capital, Mechanism Capital, MetaProp Ventures, Pareto Holdings, Trammell Venture Partners, Unpopular Ventures, Baron Davis, Johannes De Waal, Matthew Dellavedova, Stephen Cole.
Key people at EQUIP.
Equip is a San Diego-based health technology company providing virtual, evidence-based treatment programs for eating disorders, delivering care remotely through a dedicated five-person team per patient—including a therapist, dietitian, physician, peer mentor, and family mentor.[2][3] It serves patients in their homes, addressing a critical gap in accessible mental health care for conditions like anorexia and bulimia, where traditional in-person treatment is often limited by geography, cost, and specialist shortages.[2][5] At Series C stage with over $189 million in total funding—including a $47 million raise in 2025 and $110 million in February 2025—Equip demonstrates strong growth momentum, employing over 250 staff, partnering with health plans, and earning recognitions like TIME's Top HealthTech Companies of 2025.[2][5][6]
Equip was founded in 2019 by Kristina Saffran (CEO) and Erin Parks (Chief Clinical Officer), both experts in eating disorders—Saffran as a recovered patient and Parks with clinical background; the company started as Barcada Health in San Diego (later Carlsbad), CA.[2][3] The idea emerged from the founders' recognition of outdated, inaccessible treatment models, aiming to scale family-based care virtually for lasting recovery at home.[3] Early traction came via initial investments from F-Prime Capital in 2019, enabling rapid scaling; pivotal moments include raising $35 million in April 2024, a $47 million equity round in July 2025, and $110 million in February 2025, alongside high-profile support like actress Kerry Washington's investment and advisory role.[2][5][6]
Equip rides the telehealth boom in mental health, particularly for eating disorders—a segment strained by uneven demand, specialist scarcity, high costs, and cultural factors like fitness trends amplified by GLP-1 weight-loss drugs (e.g., Ozempic), which may influence treatment paradigms.[5] Timing is ideal post-pandemic, with virtual care normalizing and payers favoring cost-effective models; Equip influences the ecosystem by publishing research, expanding health plan access, and proving digital scalability in a field where patients face 16.6 years shorter life expectancy without intervention.[2][5] It counters operational challenges in eating disorder care, potentially setting standards for family-involved virtual therapy amid rising awareness and funding.
Equip's trajectory points to aggressive expansion: scaling team size, deepening health plan partnerships, and integrating emerging therapies like GLP-1s while researching underserved groups.[2][5] Trends like AI-enhanced care personalization, payer adoption of virtual mental health, and post-GLP-1 shifts in body image treatment will shape it, potentially evolving Equip into a dominant player in digital behavioral health.[5] With $189M+ raised and Series C stability, its influence could redefine accessible recovery, turning a niche crisis into a scalable solution—building on its bold origins to deliver "lasting recovery at home."[3]
EQUIP has raised $400K across 1 funding round. Most recently, it raised $400K Seed in April 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2022 | $400K Seed | GateCap Ventures, MaC Venture Capital, Mechanism Capital, MetaProp Ventures, Pareto Holdings, Trammell Venture Partners, Unpopular Ventures, Baron Davis, Johannes De Waal, Matthew Dellavedova, Stephen Cole |
